Nanotechnology healthcare is defined as the application of nanotechnology in healthcare. In context to the human body, Nanotechnology healthcare is the repair, construction, monitoring and control of biological systems at sub-microscopic and molecular levels with the help of engineered nanostructures and nanodevices. It finds application for the purpose of disease diagnosis, prevention, and therapy. These objectives can be fulfilled by utilizing nano-molecular tools and the knowledge obtained from the human body using them. Nanotechnology healthcare caters to some of the major disease segments such as cancer, diabetes cardiovascular, musculoskeletal, neurodegenerative and infectious diseases. Growing global prevalence of such diseases is expected to serve as a high impact driver for this market.
In addition, the growth in the size of the geriatric population base triggering the incidence rates of cardiovascular and neurology based diseases and the growing number of research and development programs funded by governments and other private institutions is expected to drive market growth during the forecast period. Nanotechnology healthcare being an emerging trend in healthcare holds immense growth opportunities in the foreseeable future. The existing pharmaceutical and medical devices market players are readily entering this field in an attempt to capitalize the available potential for growth. The future growth is expected to be further propelled by the presence of an in-depth product pipeline line-up as a consequent effect of a large number of R&D initiatives which are undertaken by manufacturers. There is also an increase in demand for nanotechnology healthcare based funding in emerging markets of Russia, India, and China. The global healthcare nanotechnology market was valued at USD 96.22 billion in 2012 and is expected to grow at a CAGR of 12.1% over the next six years.
Nanotechnology healthcare has applications in a broad range of human body related aspects of medical diagnosis, therapy, and repair. These are divided into drug delivery applications, molecular diagnostics and clinical applications in oncology, neurology, cardiology, anti-inflammatory and anti-infective segments. Oncology dominated the overall application market in terms of revenue share at 35% of the market in 2013. Relatively higher efficacy demonstrated by nanomaterials is one of the key reasons attributing to its large share. Moreover the ability of nano-particles to move across the blood brain barrier will facilitate breakthrough innovations and thus will expedite the technological advancement of cancer therapy. The cardiovascular application segment for healthcare nanotechnology is expected to grow at the highest CAGR over the next six years. The presence of high unmet medical needs in this segment coupled with rapidly growing incidence rates of cardiovascular disorders owing to changing lifestyles is expected to boost segment demand.
Major geographies analyzed and estimated in this study include North America, Europe, Asia-Pacific and RoW. North America currently holds the largest share of the overall nanotechnology healthcare market accounting for over 38% of the market revenue. The presence of sophisticated healthcare infrastructure and funding programs supporting research and development initiatives attributes to its large market share. In addition, the region’s sophisticated healthcare infrastructure and external funding provisions enable the development and use of advanced products such as nanorobots, nanoprobes, nanoparticle imaging reagents and immunoassays based on monoclonal antibodies. However, owing to the rising number of research and development exercises conducted in emerging countries such as India and China and the presence of an extensive nanotechnology healthcare based product pipeline portfolio, the Asia-Pacific region is expected to grow at the highest CAGR of 14.2% over the forecast period.
Key players of this market include UCB SA, Sigma-Tau Pharmaseuticals Inc., Teva Pharmaceuticals Industries Ltd., Pfizer Inc., Merck& Company Inc., Nanosphere Inc., Johnson & Johnson, GE Healthcare, Celgene Corporation, Mallinckrodt plc., CombiMatrix Corporation and Abbott Laboratories.
Grand View Research offers special pricing for:
Get your queries resolved from an industry expert. Request for a free product review before report purchase.
Speak to the report author to design an exclusive study to serve your research needs.
A testimonial for service excellence represented in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.